NewConnect-listed biotech company Pharmena established a special purpose company Menavitin in Germany. Menavitin will sell dietary supplements containing 1-MNA on the German, Austrian and Swiss markets, Pharmena said. It owns 92.5 percent shares in Menavitin. The remaining 7.5 percent belong to Frit...
- Poland AM
- Our Products